Development of receptor-based inhibitory RNA aptamers for anthrax toxin neutralization
- 1 June 2015
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 77, 293-302
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science, ICT & Future Planning, Republic of Korea
- Bio-Industry Technology Development Program, Ministry of Food, Agriculture, Forestry and Fisheries, Republic of Korea
This publication has 33 references indexed in Scilit:
- Selection and Identification of a DNA Aptamer Targeted to Vibrio parahemolyticusJournal of Agricultural and Food Chemistry, 2012
- Nucleotide Bias Observed with a Short SELEX RNA Aptamer LibraryNucleic Acid Therapeutics, 2011
- Screening and Characterization of High-Affinity ssDNA Aptamers against Anthrax Protective AntigenSLAS Discovery, 2011
- Aptamers for Targeted Drug DeliveryPharmaceuticals, 2010
- Raxibacumab for inhalational anthrax: an effective specific therapeutic approach?Expert Opinion on Investigational Drugs, 2010
- Humans and evolutionary and ecological forces shaped the phylogeography of recently emerged diseasesNature Reviews Microbiology, 2009
- Pathophysiology of anthraxFrontiers in Bioscience-Landmark, 2009
- Single-stranded DNA aptamers specific for antibiotics tetracyclinesBioorganic & Medicinal Chemistry, 2008
- Polyvalent inhibitors of anthrax toxin that target host receptorsProceedings of the National Academy of Sciences, 2006
- In Vitro Selection of RNA Aptamers That Bind to Cell Adhesion Receptors of Trypanosoma cruzi and Inhibit Cell InvasionJournal of Biological Chemistry, 2002